In our study, we compared CD4+ T cell immunity to BCG, Tetanus and Pertussis vaccines in two cohorts of newborn infants recruited from Jos, Nigeria and Khayelitsha, Cape Town, South Africa, and then interrogated the effects of BCG strain further in the Cape Town cohort. The gene discussed is CD4; the disease is pertussis.